Glaxosmithkline





Ebit Cambio Fecha
AbbVie USD 5.81B 4.36B 2025-12
Amgen USD 3.96B 464M 2025-12
AstraZeneca USD 2.97B 4.48B 2025-12
Aurora Cannabis CAD -44.75M 27.14M 2025-09
Bausch Health Companies USD 717M 112M 2025-09
Bristol-Myers Squibb USD 3.47B 567M 2025-12
Canopy Growth CAD -14.3M 17.19M 2025-09
Corcept Therapeutics USD 10.22M 16.46M 2025-09
Drreddys Laboratories INR 16.37B 3.5B 2025-12
Eli Lilly USD 8.99B 1.57B 2025-12
GlaxoSmithKline GBP 1.44B 1.35B 2025-12
Glaxosmithkline GBP 3.76B 1.69B 2025-09
J&J USD 5.11B 2.3B 2025-12
Merck USD 6.24B 1.32B 2025-12
Novartis USD -9.19B 13.87B 2025-06
Pacira USD 13.15M 2.92M 2025-09
Perrigo USD 93.4M 37.8M 2025-09
Pfizer USD 4.65B 71M 2025-12
Phibro Animal Health USD 26M 5.54M 2024-09
Prestige Brands USD 82.49M 2.82M 2025-12
Roche Holding CHF 9.56B 2.1B 2025-12
Sanofi EUR 1.7B 2.17B 2025-12
Supernus Pharmaceuticals USD -60.18M 72.33M 2025-09
Takeda JPY 257.49B 568.56B 2025-12
Teva Pharmaceutical Industries USD 577M 491M 2025-12
Zoetis USD 835M 140M 2025-12


Glaxosmithkline - Los valores actuales, los datos históricos, las previsiones, estadísticas, gráficas y calendario económico - Feb 2026.